MedPath
HSA Approval

ALZENTAL TABLET 400 mg

SIN07903P

ALZENTAL TABLET 400 mg

ALZENTAL TABLET 400 mg

November 9, 1994

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

P02CA03

albendazole

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

SHIN POONG PHARMACEUTICAL CO LTD

Active Ingredients

ALBENDAZOLE

400 mg

Albendazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.